Departments of Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California.
Departments of Purification Development, Genentech, Inc., 1 DNA Way, South San Francisco, California.
Biotechnol Bioeng. 2020 Jul;117(7):1946-1960. doi: 10.1002/bit.27347. Epub 2020 Apr 21.
Optimal production of bispecific antibodies (bsAb) requires efficient and tailored co-expression and assembly of two distinct heavy and two distinct light chains. Here, we describe a novel technology to modulate the translational strength of antibody chains via Kozak sequence variants to produce bsAb in a single cell line. In this study, we designed and screened a large Kozak sequence library to identify 10 independent variants that can modulate protein expression levels from approximately 0.2 to 1.3-fold compared with the wild-type sequence in transient transfection. We used a combination of several of these variants, covering a wide range of translational strength, to develop stable single cell Chinese hamster ovary bispecific cell lines and compared the results with those obtained from the wild-type sequence. A significant increase in bispecific antibody assembly with a concomitant reduction in the level of product-related impurities was observed. Our findings suggest that for production of bsAb it can be advantageous to modify translational strength for selected protein chains to improve overall yield and product quality. By extension, tuning of translational strength can also be applied to improving the production of a wide variety of heterologous proteins.
生产双特异性抗体(bsAb)需要有效地表达和组装两种不同的重链和两种不同的轻链。在此,我们描述了一种通过 Kozak 序列变体来调节抗体链翻译强度的新技术,可在单个细胞系中生产 bsAb。在这项研究中,我们设计并筛选了一个大型 Kozak 序列文库,以鉴定出 10 种独立的变体,与瞬时转染中的野生型序列相比,其蛋白表达水平可调节约 0.2 至 1.3 倍。我们使用这些变体中的几种组合,涵盖了广泛的翻译强度范围,来开发稳定的单个中国仓鼠卵巢细胞双特异性细胞系,并将结果与野生型序列的结果进行比较。观察到双特异性抗体组装的显著增加,同时产品相关杂质的水平降低。我们的发现表明,对于 bsAb 的生产,修饰选定蛋白链的翻译强度以提高整体产率和产品质量可能是有利的。可以推广,调节翻译强度也可应用于提高各种异源蛋白的生产。